Tissue-Specific Effects of Central Leptin on the Expression of Genes Involved in Lipid Metabolism in Liver and White Adipose Tissue
- 1 December 2007
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 148 (12) , 5604-5610
Abstract
Leptin reduces adiposity and exerts antisteatotic effects on nonadipose tissues. However, the mechanisms underlying leptin effects on lipid metabolism in liver and white adipose tissue have not been fully clarified. Here, we have studied the effects of central leptin administration on key enzymes and transcription factors involved in lipid metabolism in liver and epididymal adipose tissue. Intracerebroventricular leptin infusion for 7 d did not change leptin plasma levels but decreased triacylglyceride content in liver, epididymal adipose tissue, and plasma. In both tissues this treatment markedly decreased the expression of key enzymes of the de novo fatty acid (FA) synthesis such as acetyl-coenzyme A-carboxylase, FA synthase, and stearoyl-coenzyme A desaturase-1, in parallel with a reduction in mRNA expression of sterol regulatory element binding protein-1c in liver and carbohydrate regulatory element binding protein in adipose tissue. In addition, leptin also decreased phosphoenol-pyruvate carboxykinase-C expression in adipose tissue, an enzyme involved in glyceroneogenesis in this tissue. Central leptin administration down-regulates delta-6-desaturase expression in liver and adipose tissue, in parallel with the decrease of the expression of sterol regulatory element binding protein-1c in liver and peroxisome proliferator activated receptor α in adipose tissue. Finally, leptin treatment, by regulating adipose triglyceride lipase/hormone sensitive lipase/diacylglycerol transferase 1 expression, also established a new partitioning in the FA-triacylglyceride cycling in adipose tissue, increasing lipolysis and probably the FA efflux from this tissue, and favoring in parallel the FA uptake and oxidation in the liver. These results suggest that leptin, acting at central level, exerts tissue-specific effects in limiting fat tissue mass and lipid accumulation in nonadipose tissues, preventing the development of obesity and type 2 diabetes.Keywords
This publication has 37 references indexed in Scilit:
- Liver Triglyceride Secretion and Lipid Oxidative Metabolism Are Rapidly Altered by Leptin in VivoEndocrinology, 2006
- Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic SyndromeEndocrinology, 2003
- Leptin Activates Cardiac Fatty Acid Oxidation Independent of Changes in the AMP-activated Protein Kinase-Acetyl-CoA Carboxylase-Malonyl-CoA AxisJournal of Biological Chemistry, 2002
- Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight LossScience, 2002
- Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearanceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2001
- Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic isletsProceedings of the National Academy of Sciences, 2000
- Lipoapoptosis in Beta-cells of Obese Prediabeticfa/fa RatsJournal of Biological Chemistry, 1998
- Leptin Directly Alters Lipid Partitioning in Skeletal MuscleDiabetes, 1997
- Direct antidiabetic effect of leptin through triglyceride depletion of tissuesProceedings of the National Academy of Sciences, 1997
- Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapyProceedings of the National Academy of Sciences, 1996